Allogene Therapeutics, Inc. (ALLO) — 10-K/A Filings
All 10-K/A filings from Allogene Therapeutics, Inc.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (1)
-
Allogene Therapeutics Files 10-K/A Amendment
— Mar 14, 2024 Risk: low
Allogene Therapeutics, Inc. (ALLO) filed a Amended Annual Report (10-K/A) with the SEC on March 14, 2024. This filing is an amendment to the 10-K for the fiscal
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX